Skip to content

Amygdala Memory Enhancement

Mechanisms of Amygdala-Mediated Memory Enhancement in Humans

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05065450
Enrollment
90
Registered
2021-10-04
Start date
2021-11-01
Completion date
2027-11-01
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Diseases, Cognitive Impairment, Epilepsy, Memory Disorders, Post Traumatic Stress Disorder, Traumatic Brain Injury

Brief summary

The objective is to understand how amygdala activation affects other medial temporal lobe structures to prioritize long-term memories. The project is relevant to disorders of memory and to disorders involving affect and memory, including traumatic brain injury and post-traumatic stress disorder.

Detailed description

Direct electrical stimulation (DES) of the basolateral complex of the amygdala (BLA) can improve declarative memory, reflecting the role of the BLA in modulating memory processes in medial temporal lobe (MTL) regions as a function of emotional arousal. Thus, DES can reveal mechanisms of BLA-mediated memory enhancement relevant to human mental health and disease. DES of the BLA can be used to interrogate the function of memory circuits, especially how neuronal oscillations in the MTL support declarative memory. First, BLA is hypothesized to wield the capacity to prioritize long-term retention of information initially encountered adjacent in time over days and weeks after encoding. Second, the BLA preferentially projects to anterior MTL regions and thus is hypothesized to preferentially modulate memory processes in those anatomic regions, processes thought to support memory for non-spatial items more so than memory for spatial locations. Third, although emotional arousal, amygdala activity, MTL activity, and memory performance are typically correlated, the investigators hypothesize that DES will reveal that BLA outputs to other MTL regions cause improved memory performance by directly eliciting pro-memory oscillatory states in those networks. The expected outcomes represent a significant advancement for the basic science of normal memory function and significant movement towards novel therapeutics designed to emulate endogenous mechanisms of memory enhancement.

Interventions

DEVICEIntracranial Stimulation

Electrodes localized to the BLA will be stimulated with either active-BLAES (0.5-3.5 mA, theta-modulated gamma burst) electrical stimulation for a 1-sec duration immediately following item image presentation or sham-BLAES (zero-amplitude). At later stages of the project, stimulation parameters and timing will be varied and triggered not at random, but by real-time closed-loop analysis of memory biomarkers in the medial temporal lobe.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Must be able to understand and speak English. * Able to provide informed consent. * Diagnosed with epilepsy. * Scheduled to undergo long-term intra-cranial video monitoring for seizure onset localization. * Must be implanted with intracranial depth electrodes to the left or right amygdala, hippocampus, and parahippocampal/perirhinal cortices.

Exclusion criteria

* Unable to understand and speak English. * Unable to provide informed consent. * Not diagnosed with epilepsy.

Design outcomes

Primary

MeasureTime frameDescription
Free recall memory discriminability index (proportion recalled)5 yearsProportion of items (objects, associations, and scenes) accurately recalled during the delayed recall trial will be compared with and without BLAES for each participant in a within subject design. Subsets of items may be tested after durations up to a month after initial presentation.
Recognition memory discriminability index (proportion recalled)5 yearsProportion of items (objects, associations, and scenes) accurately recognized during the delayed recognition trial will be compared with and without BLAES for each participant in a within subject design. Subsets of items may be tested after durations up to a month after initial presentation.

Secondary

MeasureTime frameDescription
Latency of SPEP response to amygdala stimulation5 yearsMeasured in milliseconds.
Location of single pulse evoked potential (SPEP) response to amygdala stimulation5 yearsMeasured by presence of the evoked potential in different brain subregions (hippocampus, entorhinal cortex, perirhinal cortex, and parahippocampal cortex).
LFP of bad memory state5 yearsMeasured by relative power spectral frequency recorded at the time of item presentation that predicts inaccurate subsequent memory performance
Local field potential (LFP) of good memory state5 yearsMeasured by relative power spectral frequency recorded at time of item presentation that predicts accurate subsequent memory performance.
Amplitude of SPEP response to amygdala stimulation5 yearsMeasured in microvolts.

Countries

United States

Contacts

Primary ContactJoan Atencio
atencio@wustl.edu314-362-3114
Backup ContactSophie Church
sophie.church@wustl.edu917-699-9097

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026